Pulmatrix, Inc. (PULM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on February 15, 2022. The filing addresses a material event regarding the Company's continued listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing requirements.
Material Changes and Events
- Nasdaq Non-Compliance: The Company previously received notice on August 17, 2021, that it failed to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days.
- Compliance Extension: On February 15, 2022, Nasdaq granted the Company an additional 180-day compliance period, extending the deadline to August 15, 2022.
- Conditions for Extension: The extension was granted because the Company met all other listing requirements, including the market value of publicly held shares, and submitted a written notice of intent to cure the deficiency, potentially via a reverse stock split.
Outlook, Risks, and Contingencies
There is no assurance that the Company will regain compliance with the Minimum Bid Price Requirement by the new deadline of August 15, 2022. If compliance is not demonstrated by that date, Nasdaq may issue a notification that the Company's common stock could be delisted. The Company retains the right to appeal any delisting determination to a Nasdaq Hearings Panel.
Key Facts for Investor Verification
- Verify the current trading price of PULM common stock to assess the likelihood of meeting the $1.00 minimum bid price requirement.
- Monitor for announcements regarding a potential reverse stock split to cure the deficiency.
- Track the August 15, 2022 deadline for the final determination on listing status.
- Review subsequent filings for any updates on the Company's financial condition or capitalization changes.